CHURC1

gene
On this page

Also known as My015FLJ33064

Summary

CHURC1 (churchill domain containing 1, HGNC:20099) is a protein-coding gene on chromosome 14q23.3, encoding Protein Churchill (Q8WUH1). Transcriptional activator that mediates FGF signaling during neural development.

Predicted to enable zinc ion binding activity. Predicted to be involved in fibroblast growth factor receptor signaling pathway.

Source: NCBI Gene 91612 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 16 total
  • MANE Select transcript: NM_001386928

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20099
Approved symbolCHURC1
Namechurchill domain containing 1
Location14q23.3
Locus typegene with protein product
StatusApproved
AliasesMy015, FLJ33064
Ensembl geneENSG00000258289
Ensembl biotypeprotein_coding
OMIM608577
Entrez91612

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 10 protein_coding, 1 retained_intron

ENST00000547625, ENST00000548752, ENST00000549115, ENST00000551093, ENST00000551947, ENST00000552002, ENST00000556089, ENST00000607599, ENST00000882584, ENST00000927076, ENST00000927077

RefSeq mRNA: 3 — MANE Select: NM_001386928 NM_001204064, NM_001386928, NM_145165

CCDS: CCDS32101, CCDS55921, CCDS55922

Canonical transcript exons

ENST00000549115 — 4 exons

ExonStartEnd
ENSE000035443056492601064926080
ENSE000035740236492399164924126
ENSE000036965666491445564914534
ENSE000036967006493213864935368

Expression profiles

Bgee: expression breadth ubiquitous, 256 present calls, max score 98.31.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 66.2178 / max 819.9124, expressed in 1824 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
14013566.21781824

Top tissues by expression

256 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370198.31gold quality
left ventricle myocardiumUBERON:000656696.77gold quality
right coronary arteryUBERON:000162596.75gold quality
hindlimb stylopod muscleUBERON:000425296.56gold quality
tibial arteryUBERON:000761096.41gold quality
popliteal arteryUBERON:000225096.40gold quality
upper arm skinUBERON:000426396.21gold quality
left coronary arteryUBERON:000162696.17gold quality
monocyteCL:000057696.07gold quality
islet of LangerhansUBERON:000000695.94gold quality
coronary arteryUBERON:000162195.92gold quality
leukocyteCL:000073895.90gold quality
aortaUBERON:000094795.87gold quality
cardiac muscle of right atriumUBERON:000337995.76gold quality
smooth muscle tissueUBERON:000113595.67gold quality
descending thoracic aortaUBERON:000234595.56gold quality
muscle of legUBERON:000138395.33gold quality
thoracic aortaUBERON:000151595.27gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047395.24gold quality
ascending aortaUBERON:000149695.24gold quality
gastrocnemiusUBERON:000138895.20gold quality
skin of hipUBERON:000155495.19gold quality
endothelial cellCL:000011594.86gold quality
epithelial cell of pancreasCL:000008394.83gold quality
superficial temporal arteryUBERON:000161494.47gold quality
visceral pleuraUBERON:000240194.47gold quality
muscle tissueUBERON:000238594.44gold quality
vermiform appendixUBERON:000115494.41gold quality
myocardiumUBERON:000234994.41gold quality
parietal pleuraUBERON:000240094.41gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

113 targeting CHURC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-126-5P100.0072.713180
HSA-MIR-6740-5P100.0065.64932
HSA-MIR-4262100.0073.263931
HSA-MIR-186-5P99.9970.833707
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-569699.9872.364487
HSA-MIR-302E99.9670.742669
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-55999.9572.283609
HSA-MIR-548AB99.9571.313488
HSA-MIR-548A-5P99.9471.273482
HSA-MIR-548AD-5P99.9471.233502
HSA-MIR-548AE-5P99.9471.233502
HSA-MIR-548AK99.9471.243488
HSA-MIR-548AM-5P99.9471.243488
HSA-MIR-548AP-5P99.9471.143489
HSA-MIR-548AQ-5P99.9471.343426
HSA-MIR-548AR-5P99.9471.283515
HSA-MIR-548AS-5P99.9471.223482
HSA-MIR-548AU-5P99.9471.243488
HSA-MIR-548AY-5P99.9471.233502
HSA-MIR-548B-5P99.9471.233502
HSA-MIR-548BB-5P99.9471.273509
HSA-MIR-548C-5P99.9471.243488
HSA-MIR-548D-5P99.9471.233502
HSA-MIR-548H-5P99.9471.243488

Literature-anchored findings (GeneRIF, showing 2)

  • Embryonic neural inducing factor churchill is not a DNA-binding zinc finger protein: solution structure reveals a solvent-exposed beta-sheet and zinc binuclear cluster (PMID:17610897)
  • This is the first implication of chr14q23.2-23.3 in the etiology of autism and points to MTHFD1, PLEKHG3, and CHURC1 as potential candidate genes contributing to autism risk. (PMID:21360829)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriochurc1ENSDARG00000010831
mus_musculusChurc1ENSMUSG00000090258
rattus_norvegicusFntbENSRNOG00000007660

Protein

Protein identifiers

Protein ChurchillQ8WUH1 (reviewed: Q8WUH1)

All UniProt accessions (4): B7Z3N2, Q8WUH1, H0YHB4, H0YID9

UniProt curated annotations — full annotation on UniProt →

Function. Transcriptional activator that mediates FGF signaling during neural development. Plays a role in the regulation of cell movement. Does not bind DNA by itself.

Similarity. Belongs to the Churchill family.

Isoforms (4)

UniProt IDNamesCanonical?
Q8WUH1-44yes
Q8WUH1-11
Q8WUH1-22
Q8WUH1-33

RefSeq proteins (3): NP_001190993, NP_001373857, NP_660148 (=MANE)

Domains & families (InterPro)

IDNameType
IPR009508Transcrpt_activator_ChurchillFamily
IPR038543Churchill_sfHomologous_superfamily

Pfam: PF06573

UniProt features (27 total): binding site 12, strand 7, splice variant 4, turn 3, chain 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
2JOXSOLUTION NMR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8WUH1-F193.790.85

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (12): 2; 71; 88; 91; 5; 30; 30; 33; 59; 61; 64; 66

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 115 (showing top): WANG_LMO4_TARGETS_DN, GOBP_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR, GOBP_RESPONSE_TO_GROWTH_FACTOR, chr14q23, GOBP_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY, ZHENG_BOUND_BY_FOXP3, GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY, GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY, BANP_TARGET_GENES, CBX7_TARGET_GENES, DYRK1A_TARGET_GENES, ELF2_TARGET_GENES, HOXB6_TARGET_GENES, IRF5_TARGET_GENES, ZNF146_TARGET_GENES

GO Biological Process (3): fibroblast growth factor receptor signaling pathway (GO:0008543), positive regulation of DNA-templated transcription (GO:0045893), multicellular organism development (GO:0007275)

GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cell surface receptor protein tyrosine kinase signaling pathway1
cellular response to fibroblast growth factor stimulus1
DNA-templated transcription1
regulation of DNA-templated transcription1
positive regulation of RNA biosynthetic process1
multicellular organismal process1
anatomical structure development1
transition metal ion binding1
binding1
cation binding1

Protein interactions and networks

STRING

710 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CHURC1ZEB2O60315797
CHURC1SERPINA3P01011412
CHURC1PCDH17O14917406
CHURC1FCGBPQ9Y6R7404
CHURC1NPTX2P47972396
CHURC1NPAS4Q8IUM7395
CHURC1HLA-DPA1P01905389
CHURC1C1QCP02747383
CHURC1SIRAL2Q9NWS6371
CHURC1FNTBP49356370
CHURC1CFAP68Q9H5F2370
CHURC1IGF1P01343370
CHURC1PLEKHG3A1L390369
CHURC1CIMAP1DQ3SX64355
CHURC1MRPL43Q8N983349

IntAct

15 interactions, top by confidence:

ABTypeScore
ARPC4ARPC1Bpsi-mi:“MI:0914”(association)0.910
ACTR3BARPC2psi-mi:“MI:0914”(association)0.670
CHURC1ZNF581psi-mi:“MI:0915”(physical association)0.560
CHURC1ZBTB9psi-mi:“MI:0915”(physical association)0.370
SERTAD1CHURC1psi-mi:“MI:0915”(physical association)0.370
ACTR2PPP1R12Apsi-mi:“MI:0914”(association)0.350
ACTR3BARPC2psi-mi:“MI:0914”(association)0.350
ACTR2psi-mi:“MI:0914”(association)0.350
ARPC3psi-mi:“MI:0914”(association)0.350
GOSR1NBASpsi-mi:“MI:0914”(association)0.350
CHURC1NMT2psi-mi:“MI:0914”(association)0.350
CHURC1ZNF581psi-mi:“MI:0915”(physical association)0.000

BioGRID (28): CHURC1 (Affinity Capture-MS), CHURC1 (Affinity Capture-MS), CHURC1 (Two-hybrid), CHURC1 (Affinity Capture-MS), CHURC1 (Affinity Capture-MS), CHURC1 (Affinity Capture-MS), ARPC3 (Affinity Capture-MS), ACTR2 (Affinity Capture-MS), ARPC1A (Affinity Capture-MS), ARPC5 (Affinity Capture-MS), ACTR3 (Affinity Capture-MS), CHURC1 (Affinity Capture-MS), ACTR3B (Affinity Capture-MS), UBB (Affinity Capture-MS), GLRX (Affinity Capture-MS)

ESM2 similar proteins: A0L3X0, A0RMQ6, A1SYJ9, A1VAL0, A1VXN9, A4XJM8, A5G8U0, A5ILC5, A5N3K1, A6Q6S1, A8FJW4, A9BJ07, B0K1F3, B0K7H0, B0S2B9, B2TJY1, B2UZI1, B8DRV3, B8FEA3, B8FZ78, B8GPB9, B9DX85, B9MR65, C0H406, C0H410, O31798, O48425, O54311, P03769, P9WK08, P9WK09, Q24ML8, Q2HJG7, Q30P97, Q30X20, Q38490, Q3A127, Q3IJB4, Q5HX10, Q5R6Q5

Diamond homologs: Q2HJG7, Q5R6Q5, Q5U3N7, Q66JD9, Q6DG52, Q8WUH1, Q9DFZ3, Q9DFZ4

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 13 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

GO biological processes:

GO termPartnersFoldFDR
Arp2/3 complex-mediated actin nucleation5438.9×1e-11

Disease & clinical

Clinical variants and AI predictions

ClinVar

16 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance14
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1036 predictions. Top by Δscore:

VariantEffectΔscore
14:64923989:A:AGacceptor_gain1.0000
14:64923989:AG:Aacceptor_gain1.0000
14:64923990:G:Aacceptor_gain1.0000
14:64923990:G:GGacceptor_gain1.0000
14:64923990:GGGT:Gacceptor_gain1.0000
14:64923990:GGGTA:Gacceptor_gain1.0000
14:64924122:TGATC:Tdonor_gain1.0000
14:64924123:GATC:Gdonor_gain1.0000
14:64924123:GATCG:Gdonor_gain1.0000
14:64924124:ATC:Adonor_gain1.0000
14:64924125:TC:Tdonor_gain1.0000
14:64924126:CG:Cdonor_loss1.0000
14:64924127:G:Adonor_loss1.0000
14:64924127:G:GGdonor_gain1.0000
14:64924128:TAA:Tdonor_loss1.0000
14:64930875:G:GTdonor_gain1.0000
14:64939834:TTCTC:Tacceptor_gain1.0000
14:64939836:CTC:Cacceptor_gain1.0000
14:64939838:CCTAG:Cacceptor_loss1.0000
14:64939839:C:CCacceptor_gain1.0000
14:64939840:T:Gacceptor_loss1.0000
14:64942499:CCTCA:Cdonor_loss1.0000
14:64942500:CTCA:Cdonor_loss1.0000
14:64942501:TCAC:Tdonor_loss1.0000
14:64942502:CA:Cdonor_loss1.0000
14:64942503:ACCTG:Adonor_loss1.0000
14:64942504:CCTGA:Cdonor_loss1.0000
14:64914533:GG:Gdonor_gain0.9900
14:64914534:GG:Gdonor_gain0.9900
14:64914535:G:GGdonor_gain0.9900

AlphaMissense

926 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:64924039:T:CC57R0.999
14:64926015:T:CC88R0.999
14:64926057:T:CF102L0.999
14:64926059:C:AF102L0.999
14:64926059:C:GF102L0.999
14:64932153:T:CC115R0.999
14:64932155:T:GC115W0.999
14:64932162:T:CC118R0.999
14:64932163:G:AC118Y0.999
14:64932164:C:GC118W0.999
14:64932165:G:CG119R0.999
14:64932166:G:AG119D0.999
14:64924029:C:AN53K0.998
14:64924029:C:GN53K0.998
14:64924039:T:AC57S0.998
14:64924040:G:CC57S0.998
14:64924048:T:CC60R0.998
14:64926015:T:AC88S0.998
14:64926016:G:CC88S0.998
14:64926017:T:GC88W0.998
14:64926039:G:CA96P0.998
14:64926040:C:AA96D0.998
14:64926045:C:GH98D0.998
14:64932154:G:AC115Y0.998
14:64932160:T:CL117S0.998
14:64932162:T:AC118S0.998
14:64932163:G:CC118S0.998
14:64932163:G:TC118F0.998
14:64932165:G:TG119C0.998
14:64932166:G:TG119V0.998

dbSNP variants (sampled 300 via entrez): RS1000405287 (14:64914216 C>T), RS1000469258 (14:64922533 G>A), RS1000488309 (14:64925833 G>A,T), RS1000641784 (14:64931629 A>G), RS1000837619 (14:64926142 C>A,G), RS1001099578 (14:64916805 C>T), RS1001254721 (14:64928897 A>G,T), RS1001441949 (14:64928760 C>G,T), RS1001459828 (14:64914870 A>G,T), RS1001566166 (14:64928287 G>A,T), RS1001863267 (14:64928180 G>A,T), RS1001899570 (14:64918400 C>G), RS1002089957 (14:64921994 G>A,C), RS1002111616 (14:64924863 T>C), RS1002258761 (14:64930199 C>G,T)

Disease associations

OMIM: gene MIM:608577 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST003518_66Daytime sleep phenotypes4.000000e-06
GCST004862_27Itch intensity from mosquito bite adjusted by bite size6.000000e-07
GCST90002397_360Mean spheric corpuscular volume6.000000e-10

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0007828daytime rest measurement
EFO:0008377mosquito bite reaction itch intensity measurement
EFO:0008378mosquito bite reaction size measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB clinical annotations

1 annotations.

VariantTypeLevelDrugsPhenotypes
rs4902333Efficacy3methylphenidateAttention Deficit Disorder with Hyperactivity

CTD chemical–gene interactions

16 total (human), top 16 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression3
Cocainedecreases expression2
aristolochic acid Iincreases expression1
methylmercuric chloridedecreases expression1
uranyl acetateincreases expression1
methylparabendecreases expression1
CGP 52608affects binding, increases reaction1
Sunitinibdecreases expression1
Benzo(a)pyreneaffects methylation1
Heroindecreases expression1
Smokedecreases expression1
Uraniumincreases expression1
Urethanedecreases expression1
Sodium Seleniteincreases expression1
Okadaic Aciddecreases expression1
Particulate Matterincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.